Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
Authors
Keywords
-
Journal
Molecular Brain
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-13
DOI
10.1186/s13041-022-00964-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- [11C]PIB amyloid quantification: effect of reference region selection
- (2020) Fiona Heeman et al. EJNMMI Research
- Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s disease
- (2020) A. Inguanzo et al. PARKINSONISM & RELATED DISORDERS
- MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease
- (2019) Seok Jong Chung et al. NEUROBIOLOGY OF AGING
- What is the Physiological Function of Amyloid-Beta Protein?
- (2019) John E. Morley et al. Journal of Nutrition Health & Aging
- Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology
- (2019) Vincent Doré et al. Alzheimers & Dementia
- Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease
- (2019) Jinhee Kim et al. MOLECULAR NEUROBIOLOGY
- Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
- (2019) Tracy R. Melzer et al. Frontiers in Neurology
- Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
- (2019) Jinny Claire Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
- (2019) Christine Ghadery et al. MOLECULAR NEUROBIOLOGY
- Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging
- (2018) Lei Wu et al. HUMAN BRAIN MAPPING
- Risk factors for non-motor symptoms in Parkinson's disease
- (2018) Johan Marinus et al. LANCET NEUROLOGY
- An emergent functional parcellation of the temporal cortex
- (2018) Rebecca L. Jackson et al. NEUROIMAGE
- Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis
- (2018) Carme Uribe et al. PARKINSONISM & RELATED DISORDERS
- Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity
- (2018) Yong-ming Wang et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson’s Disease: The PPMI Dataset
- (2018) Eleonora Fiorenzato et al. JOURNAL OF ALZHEIMERS DISEASE
- Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia
- (2018) Jordi A. Matias-Guiu et al. Frontiers in Aging Neuroscience
- Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
- (2018) Jorge Sepulcre et al. NATURE MEDICINE
- 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
- (2017) Christopher C. Rowe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
- (2017) Rachael A Lawson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease
- (2017) Raluca Modreanu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Natural course of mild cognitive impairment in Parkinson disease
- (2017) Kenn Freddy Pedersen et al. NEUROLOGY
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Optimized classification of 18 F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
- (2017) Santiago Bullich et al. NeuroImage-Clinical
- Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
- (2017) Rizwan S. Akhtar et al. PLoS One
- Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
- (2017) Chelsea Caspell-Garcia et al. PLoS One
- Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson’s Disease1
- (2016) Mariateresa Buongiorno et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study
- (2016) M J Firbank et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease
- (2016) Yaroslau Compta et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Motor symptoms in Parkinson’s disease: A unified framework
- (2016) Ahmed A. Moustafa et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
- (2016) Rachael A. Lawson et al. PARKINSONISM & RELATED DISORDERS
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
- (2015) A. Gustot et al. BIOCHEMICAL JOURNAL
- Parkinson’s disease dementia: a neural networks perspective
- (2015) James Gratwicke et al. BRAIN
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
- (2015) Mark Terrelonge et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Areas of Brain Damage Underlying Increased Reports of Behavioral Disinhibition
- (2015) Kristine M. Knutson et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Correlation between decreased CSF α-synuclein and Aβ1–42 in Parkinson disease
- (2015) Chandana Buddhala et al. NEUROBIOLOGY OF AGING
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Structural neuroimaging of social cognition in progressive non-fluent aphasia and behavioral variant of frontotemporal dementia
- (2013) Blas Couto et al. Frontiers in Human Neuroscience
- Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
- (2013) Mark Broeders et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- White matter microstructure deteriorates across cognitive stages in Parkinson disease
- (2013) T. R. Melzer et al. NEUROLOGY
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Amyloid and its association with default network integrity in Alzheimer's disease
- (2012) Sofie M. Adriaanse et al. HUMAN BRAIN MAPPING
- Echoes of the Brain within the Posterior Cingulate Cortex
- (2012) R. Leech et al. JOURNAL OF NEUROSCIENCE
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- (2012) S. N. Gomperts et al. NEUROLOGY
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status
- (2011) Sook K. Song et al. MOVEMENT DISORDERS
- The serendipitous discovery of the brain's default network
- (2011) Randy L. Buckner NEUROIMAGE
- Lifespan brain activity, β-amyloid, and Alzheimer's disease
- (2011) William J. Jagust et al. TRENDS IN COGNITIVE SCIENCES
- The MoCA: Well-suited screen for cognitive impairment in Parkinson disease
- (2010) J. C. Dalrymple-Alford et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
- (2009) S. Hoops et al. NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
- (2008) David J. Gill et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started